Screening & Active Surveillance | Matthew Cooperberg, MD & Mark Moyad, MD

Screening & Active Surveillance | Matthew Cooperberg, MD & Mark Moyad, MD | PCRI

Рет қаралды 20,766

Жыл бұрын

Matthew R. Cooperberg, MD, MPH is a Professor of Urology; Epidemiology & Biostatistics and the Helen Diller Family Chair in Urology at the University of California, San Francisco. Here, he and PCRI moderator, Mark Moyad, MD, MPH discuss all of the nuances of prostate cancer screening and active surveillance.
To watch Day 1 of our 2022 Prostate Cancer Patient Conference, visit: • Active Surveillance, I... (Includes: "Active Surveillance" | Matthew Cooperberg, MD, MPH, "Incontinence & ED Medical/Surgical Treatments" | Jeffrey Brady, MD, and "Prostate Treatments & Imaging" | Eugene Kwon, MD)
To see Day 2, visit: • Radiation, Advanced Tr... (Includes: "Side Effects of Radiation Therapy" | Amar Kishan, MD, "Advanced Treatment & Side Effects" | Nicholas J. Vogelzang, MD, "2022 Update - Bring it on! 8th Annual Moyad and Scholz Free for All! Any Question on Any Aspect of Prostate Cancer!" | Mark Moyad, MD & Mark Scholz, MD
Don’t know your stage? Take the quiz: Visit www.prostatecancerstaging.org
To learn more about prostate cancer visit www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's KZfaq channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #MarkMoyadMD #MatthewCooperbergMD

Пікірлер: 23

@mals6455 Жыл бұрын

Great vid with a huge amount of valuable information. Wish this was available a few years ago. Anyone early in their journey needs to watch this several times and save it to rewatch after their urology visits.

@timothyvotaw7517 Жыл бұрын

Talk about a couple of uber-level practioners who are 100 percent dedicated to their art, which this is. I'm on the approach path as a 75 yr. old man in reasonably good health & condition, with a gradually rising PSA and two biopsy samples on the scale since last year's diagnosis, (a likely derivative from Agent Orange exposure in Vietnam 55 years ago). It matters, since my viability as a man is still important to me. These discussions are like getting a second opinion, providing the lay person/patient gets familiar with key terminology and some of the procedures at basic levels of understanding. It allows me to maximize my periodic 15 minute check-ups with my urologist. It also may extend my life. Thank you.

@TheEarlofManwhich Жыл бұрын

Just wanted to say I appreciated your thoughtful, personal, and positive message. I hope you're doing well!

@Bob-ir2bj Жыл бұрын

I can't thank you enough for taking the time to put this discussion together. I really appreciate it. I"m at low risk for the moment and will be seeing my urologist in a couple of days to discuss my recent psa number, which I won't know until my visit. After listening here, I wish I lived near an academic research center with a prostate specialty. Thank you again.

@TiHerr74 Жыл бұрын

Great program. Good to know Dr Cooperberg is here in the Bay Area. I’m a 66 yr old whose PSA rose from 2.2 to 5.4 in a single year. Was sent straight to a biopsy (negative) with a semi-annual PSA test routine. MRI was not an option with my provider. My PCP had discontinued PSA’s on my annual blood tests a few years ago without a discussion despite a family history. Self advocating was the only reason we caught the large jump.

@williamosorio1849 Жыл бұрын

pomi t

@cafireman Жыл бұрын

Tim, look into The Second Opinion, they are a non profit that helps people with limited access and resources! Is your provider Kaiser btw?

@TiHerr74 Жыл бұрын

@@cafireman - Hi there - I have full company provided insurance with Kaiser so it is not a resource limitation but more of a Kaiser policy issue.

@MM-sf3rl Жыл бұрын

Great guys!

@Giovan_Nino Жыл бұрын

So good…👌

@JustaReadingguy Жыл бұрын

So, how do we find one of these centers of excellence?

@kennethbigos4051 Жыл бұрын

Agreed... its all anyone talks about but nobody tells you where they are.

@ThePCRI Жыл бұрын

Depending on where you live, it is not always easy to know, especially if a person is not able or willing to travel to an institution with an established reputation. The most reliable way to seek out a center of excellence is to look at reputable or competitive academic institutions, listings like US News's top hospitals for cancer and top hospitals for urology, and then look through the people in the departments and see if the have medical oncologists, radiation oncologists, radiologists, urologists, and pathologists who specialize in prostate cancer or genitourinary cancers. If they are missing something, for example, if they do not have a pathologist who has a lot of experience with genitourinary cancers, you could ask what they do about that and whether they would send the results to an institution with dedicated genitourinary cancer pathologists for a second opinion. There are a lot of good smaller hospitals too, but it is hard to know if they have the best equipment, if they are up-to-date with the latest information, whether they are being as thorough as they should be, whether they are not overreacting low-grade prostate cancers, etc. without going there, asking good questions, and making sure that they are providing you with a high-level of care--and then by going somewhere else if they are not (and if it is possible). Also, for some aspects of prostate cancer-related care, you can get second opinions from large high-volume institutions without having to travel, for example, imaging results, pathology results, and sometimes consultations with doctors who specialize in genitourinary cancers if there are none in your area.

@vickyblankenship6966 Жыл бұрын

My husband is 58 and is on active surveillance for a 3+4 Gleason score after dx in March of this year. His PSA increased from 2.5 (March 2022) to 8.6 (Aug 2022). Any comments on this increase?

@scottcraig7871 Жыл бұрын

My PSA jumped from 4.7 to 8.4 after getting the Fizer jabs (I’ve only had the initial 2). My urologist said that there was data coming out at that time (January 2022) showing that there was a correlation between the jab and changes in PSA. My numbers have come down and are now stable at 6.3…..but still too high for me at 59. I had an MRI that had a pirad of 2 and a select MDX analysis that indicated my chances of cancer were very low. I’m seeing the doc again in March. Biopsy was the next step for him….I’m more inclined to continue with surveillance. Another PSA may help determine which way to go.

@JaneAtwellRobinson1825NY Жыл бұрын

My second great-grandfather Harvey Robinson actually died of cancer in his abdomen... but the primary cancer was from his prostate. They operated on this in 1920 (shudder to think HOW). You would think that because he was a farmer and wayyy back when they didn't spray with a million chemicals that people would not get cancer. This is a picture of Harvey's mom and maybe baby Harvey (all kids wore dresses then). Right now with my teens all they do is the cough test but it sounds like men shouldn't worry unless something weird happens until about 40?

@eclipsecabin7841 Жыл бұрын

As a result of the 2012 recommendation my husband ended with advance prostate cancer. Time to recognize that it was a mistake, no to screen men for prostate cancer.

@Trick_Camatry Жыл бұрын

Dr. Cooperberg says that if he sees a 45 year old patient with Gleason 6, he tells him "you won't make it to 90 years old without doing something to your prostate, but you will make it 10-20 years without doing something to it". Towards the end of the video, he makes a point that Gleason 6 doesn't behave like cancer and doesn't need treatment. If Gleason 6 doesn't need treatment, why would a 45 year old man not make it to 90 without needing to do something to his prostate? Is Dr. Cooperberg implying that Gleason 6 at a younger age indicates that there is likely a higher grade of cancer that will be found later and will need treatment? Please explain

@ThePCRI Жыл бұрын

I can add this to our list of questions for future videos. I am not sure if it was clear, but he did mean that the 45-year-old could delay treatment for another 10-20 years and that he would still be able to make it to 90 if he ended up having the prostate treated at age 55-65, but it is true that there are a lot of people on active surveillance for whom a high-grade cancer is never discovered and they therefore never have treatment (typically more than 50% of men on AS in large studies). I am not sure what percent of 45-year-old men with Gleason 6 prostate cancer would go on to develop high-grade disease and need treatment, so I will take note of your question and see if we can have Dr. Scholz or another oncologist address that.

@Trick_Camatry Жыл бұрын

@@ThePCRI thank you

@daisuke6072 Жыл бұрын

For active surveillance purposes I would advise that men don't rely on urologists - who are usually surgeons and exponents of surgery when/if treatment first raises its head, and often over-enthusiastic advocates - but take advice from an oncologist.